From: A review of outcome following valve surgery for rheumatic heart disease in Australia
Odds Ratio (95Â % CI) | All | RHD-related | Non-RHD |
---|---|---|---|
 Age (/additional year) | 1.01 (1.00 – 1.02) | - | - |
 Female sex | - | - | 1.4 (1.1 – 1.8) |
Pre-operative comorbidities | |||
 Chronic kidney disease | 2.4 (1.8 – 3.2) | 4.3 (2.0 – 9.2) | 2.6 (2.0 – 3.3) |
Pre-operative status | Â | Â | Â |
 NYHA III & IV | 1.7 (1.3 – 2.1) | - | 1.7 (1.3 – 2.2) |
 LVEF 30 – 45 % | 2.4 (1.8 – 3.2) | - | 2.4 (1.8 – 3.3) |
 LVEF <30 % | 3.5 (2.4 – 5.1) | - | 3.6 (2.5 – 5.3) |
 Mitral valve regurgitation | 1.2 (1.1 – 1.3) | - | 1.2 (1.1 – 1.2) |
 Mitral valve stenosis | 0.9 (0.8 – 0.9) | - | 0.9 (0.8 – 0.9) |
Previous procedures | Â | Â | Â |
 Valve surgery | 2.4 (1.6 – 3.4) | 2.5 (1.1 – 5.8) | 2.4 (1.6 – 3.5) |
Initial admission | |||
 ICU stay (>43 h) | 0.7 (0.6 – 0.9) | 0.3 (0.1 – 0.7) | - |
 Post procedure LOS (/additional day) | 0.97 (0.96 – 0.98) | - | 0.96 (0.95 – 0.97) |
Complications within 30Â days | |||
 Readmission | 0.4 (0.3 – 0.7) | - | 0.4 (0.2 – 0.6) |
 Re-operation for valve dysfunction | - | 27.5 (2.2 – 338.9) | - |
 Re-operation not related to valve dysfunction | 2.7 (2.0 – 3.8) | 3.3 (1.3 – 8.4) | 2.8 (2.2 – 3.9) |
 Acute kidney injury | 7.3 (5.5 – 9.8) | 7.3 (2.9 – 17.9) | 6.9 (5.1 – 9.3) |
 Stroke/ TIA | 4.6 (2.9 – 7.2) | - | 4.6 (2.8 – 7.4) |
 Anticoagulant complication | 2.9 (1.7 – 5.1) | - | 2.8 (1.5 – 5.1) |
 Septicaemia | 9.5 (6.1 – 15.27) | 9.0 (2.5 – 32.3) | 10.2 (6.3 – 16.4) |
Explained variance | |||
 (Nagelkerke R Square statistic [68]) | 24.6 % | 24.7 % | 25.1 % |